Abstract
In this work, we synthesized and characterized the properties of a series of new fluorescent DB3(n) narrow-groove ligands. DB3(n) compounds based on dimeric trisbenzimidazoles have the ability to bind to the AT regions of DNA. The synthesis of DB3(n), whose trisbenzimidazole fragments are linked by oligomethylene linkers of different lengths (n = 1, 5, 9), is based on the condensation of the MB3 monomeric trisbenzimidazole with α,ω-alkyldicarboxylic acids. DB3(n) proved to be effective inhibitors of the catalytic activity of HIV-1 integrase at submicromolar concentrations (0.20–0.30 µM). DB3(n) was found to inhibit the catalytic activity of DNA topoisomerase I at low micromolar concentrations.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS0026893323030020/MediaObjects/11008_2023_8478_Fig8_HTML.png)
Similar content being viewed by others
REFERENCES
Koval V.S., Arutyunyan A.F., Salyanov V.I., Kostyukov A.A., Melkina O.E., Zavilgelsky G.B., Klimova R.R., Kushch A.A., Korolev S.P., Agapkina Yu.Yu., Gottikh M.B., Vaiman A.V., Rybalkina E.Yu., Susova O.Yu., Zhuze A.L. 2020. DNA sequence-specific ligands. XVIII. Synthesis, physico-chemical properties; genetic, virological, and biochemical studies of fluorescent dimeric bisbenzimidazoles DBPA(n). Bioorg. Med. Chem. 28, 115378.
Bhaduri S., Ranjan N., Arya Dev P. 2018. An overview of recent advances in duplex DNA recognition by small molecules. Beilstein J. Org. Chem. 14, 1051–1086.
Rahman A., O′Sullivan P., Rozas I. 2019. Recent developments in compounds acting in the DNA minor groove. Med. Chem. Comm. 10, 26–40.
Battersby A.R. 1988. Synthetic and biosynthetic studies on vitamin B12. J. Nat. Prod. 51, 643–661.
Gudmundsson K.S., Freeman G.A., Drach J.C., Townsend L.B. 2000. Synthesis of fluorosugar analogues of 2,5,6-trichloro-1-(β-d-ribofuranosyl)benzimidazole as antivirals with potentially increased glycosidic bond stability. J. Med. Chem. 43, 2473–2478.
Skalitzky D.J., Marakovits J.T., Maegley K.A., Ekker A., Yu X.H., Hostomsky Z., Webber S.E., Eastmn B.W., Almassy R., Li J., Curtin N.J., Newell D.R., Calvert A.H., Griffin R.J., Golding B.T. 2003. Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J. Med. Chem. 46, 210–213.
He C.Y., Yang J., Wu B.-G., Risen L., Swayze E.E. 2004. Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents. Bioorg. Med. Chem. Lett. 14, 1217–1220.
Seth P.P., Miyaji A., Jefferson E.A., Kristin S.-L., Osgood S.A., Propp S.S., Ranken R., Massire C., Sampath R., Ecker D.J., Swayze E.E., Griffey R.H. 2005. SAR by MS discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain. J. Med. Chem. 48, 7099–8102.
Tanious F.A., Hamelberg D., Bailly C., Czarny A., Boykin D.W., Wilson W.D. 2004. DNA sequence dependent monomer−dimer binding modulation of asymmetric benzimidazole derivatives. J. Am. Chem. Soc. 126, 143–153.
Bailly C., Chessari G., Carrasco C., Joubert A., Mann J., Wilson W.D., Neidle S. 2003. Sequence-specific minor groove binding by bis-benzimidazoles: water molecules in ligand recognition. Nucl. Acids Res. 31, 1514–1524.
Keri R.S., Hiremathad A., Budagumpi S.I., Nagaraja B.M. 2015. Comprehensive review in current developments of benzimidazole-based medicinal chemistry. Chem. Biol. Drug Des. 86, 19–65.
Latt S.A., Stetten G., Juergens L.A., Buchanan G.R., Gerald P.S. 1975. Comprehensive review in current developments of benzimidazole-based medicinal chemistry. J. Histochem. Cytochem. 23, 493–505.
Gromyko A.V., Salyanov V.I., Strel’tsov S.A., Oleinikov V.A., Korolev S.P., Gottikh M.B., Zhuze A.L. 2007. DNA Sequence-specific ligands: XIII. New dimeric Hoechst 33258 molecules, inhibitors of HIV-1 integrase in vitro. Russ. J. Bioorg. Chemistry. 33 (6), 569–578.
Korolev S.P., Tashlitsky V.N., Smolov M.A., Gromyko A.V., Zhuze A.L., Agapkina Yu.Yu., Gottikh M.B. 2010. HIV-1 integrase inhibition by dimeric bisbenzimidazoles with different spacer structures. Mol. Biol. (Moscow). 44 (4), 633–641. https://doi.org/10.1134/S0026893310040199
Leh H., Brodin P., Bischerour J., Deprez E., Tauc P., Brochon J.C., LeCam E., Coulaud D., Auclair C., Mouscadet, J.F. 2000. Determinants of Mg-dependent activities of recombinant human immunodeficiency virus type 1 integrase. Biochemistry. 39, 9285–9294.
Yevdokimov Yu.M., Salyanov V.I., Nechipurenko Yu.D., Skuridin S.G., Zakharov M.A., Spener F., Palumbo M. 2003. Molecular constructions (superstructures) with adjustable properties based on double-stranded nucleic acids. Mol. Biol. (Moscow). 37 (2), 293‒306.
Yevdokimov Yu.M., Skuridin S.G., Nechipurenko Y.D., Zakharov M.A., Salyanov V.I., Kurnosov A.A., Kuznetsov V.D., Nikiforov V.N. 2005. Nanoconstructions based on double-stranded nucleic acids. Int. J. Biol. Macromol. 36, 103–115.
Pjura P.E., Grzeskowiak K., Dickerson R.E. 1987. Binding of Hoechst 33258 to the minor groove of B-DNA. J. Mol. Biol. 197, 257–271.
Teng M.K., Usman N., Frederick C.A., Wang A.H. 1988. The molecular structure of the complex of Hoechst 33258 and the DNA dodecamer d(CGCGAATTCGCG). Nucleic Acids Res. 16, 2671–2690.
Pommier Y., Johnson A.A., Marchand C. 2005. Integrase inhibitors to treat HIV/AIDS. Nat. Rev. Drug Discovery. 4, 236–248.
Leung C.H., Chan D.S.-H., Ma V.P.-Y., Ma D.-L. 2013. DNA-binding small molecules as inhibitors of transcription factors. Med. Res. Rev. 33, 823–846.
Funding
This work was supported by the Russian Foundation for Basic Research (no. 20-33-90287).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflicts of interest. This article does not contain a description of studies performed by the authors involving humans or using animals as objects.
Additional information
Abbreviations: topo-I, DNA topoisomerase I; HIV-1, human immunodeficiency virus type 1; scDNA, supercoiled DNA; relaxDNA,relaxed DNA; PBS, phosphate buffered saline; IC50, 50% inhibitory concentration; HBTU, (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; Boc-GlyOH, N-tert-butyloxycrbonylglycine; i-BuOC(O)Cl, isobutyl chloroformate; NMM, N-methylmorpholine; DMF, N,N-dimethylformamide; DIPEA, N,N-diisopropylethylamine.
Rights and permissions
About this article
Cite this article
Arutyunyan, A.F., Kostyukov, A.A., Korolev, S.P. et al. DNA Sequence-Specific Ligands. 19. Synthesis, Spectral Properties, Virological and Biochemical Studies of DB3(n) Fluorescent Dimeric Trisbenzimidazoles. Mol Biol 57, 512–521 (2023). https://doi.org/10.1134/S0026893323030020
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893323030020